Liver Cancer Treatment Showing Positive Results, Tulane Study Says
September 10, 2020
September 10, 2020
NEW ORLEANS, Louisiana, Sept. 10 (TNSRes) -- Tulane University issued the following news release:
Hepatocellular carcinoma is a common liver cancer with poor prognosis. With symptoms not discovered until later stages, it is considered the most fatal malignant liver cancer worldwide.
But a research team in the Tulane University Department of Biomedical Engineering is developing a novel cancer treatment that is able to shrink tumors to an average of less than 3 percent of . . .
Hepatocellular carcinoma is a common liver cancer with poor prognosis. With symptoms not discovered until later stages, it is considered the most fatal malignant liver cancer worldwide.
But a research team in the Tulane University Department of Biomedical Engineering is developing a novel cancer treatment that is able to shrink tumors to an average of less than 3 percent of . . .